---
title: "Ampio Pharma (AMPE.US) — 财务报表"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/AMPE.US/norm.md"
symbol: "AMPE.US"
name: "Ampio Pharma"
parent: "https://longbridge.com/zh-CN/quote/AMPE.US.md"
datetime: "2026-03-14T20:18:38.955Z"
locales:
  - [en](https://longbridge.com/en/quote/AMPE.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/AMPE.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/AMPE.US/norm.md)
---

> 支持的语言: [English](https://longbridge.com/en/quote/AMPE.US/norm.md) | [繁體中文](https://longbridge.com/zh-HK/quote/AMPE.US/norm.md)


# Ampio Pharma (AMPE.US) — 财务报表

## 利润表 (USD)

| 指标 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
| --- | --- | --- | --- | --- | --- |
| EPS | -2.49 | -1.53 | -1.82 | -5.27 | -3.45 |
| ROE | -188.12% | -82.38% | -75.97% | -161.81% | -69.27% |
| Revenue | - | - | - | - | - |
| Net income | -2.05M | -1.23M | -1.37M | -3.98M | -2.22M |
| Operating income | -2.21M | -1.40M | -1.56M | -4.34M | -2.70M |
| Gross margin | - | - | - | - | - |
| Net margin | - | - | - | - | - |
| Profit quality | - | - | - | - | - |

## 资产负债表 (USD)

| 指标 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
| --- | --- | --- | --- | --- | --- |
| A&L | 5.74M | 7.65M | 9.15M | 10.73M | 13.59M |
| Leverage | 1.71 | 1.42 | 1.39 | 1.36 | 1.15 |
| BVPS | 4.03 | 6.68 | 8.69 | 10.43 | 15.61 |
| Turnover | - | - | - | - | - |
| Cash & STI | 4.12M | 6.43M | 6.99M | 10.39M | 12.69M |
| Inv & Rec | - | - | - | - | - |
| LT assets | - | - | - | - | 259000.00 |
| Net debt | -3.67M | -6.07M | -6.54M | -9.85M | -11.88M |

## 现金流量表 (USD)

| 指标 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -2.31M | -555000.00 | -3.40M | -2.30M | -4.29M |
| Investing CF | - | - | - | - | - |
| Financing CF | 0.0000 | - | - | - | 0.0000 |
| Free CF | -1.73M | -113000.00 | -2.99M | -534375.00 | -3.91M |
| OCF coverage | - | - | - | - | - |
| Repaid & issued | - | - | - | - | - |
| CapEx | - | - | - | - | - |